文化大學機構典藏 CCUR:Item 987654321/48774
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 47249/51115 (92%)
造访人次 : 14027181      在线人数 : 256
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于CCUR ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://irlib.pccu.edu.tw/handle/987654321/48774


    题名: High-sensitivity troponin in chronic kidney disease: Considerations in myocardial infarction and beyond
    作者: Chuang, AN (Chuang, Anthony (Ming-yu)
    Nguyen, MT (Nguyen, Mau T.)
    Kung, WM (Kung, Woon-Man)
    Lehman, S (Lehman, Sam)
    Chew, DP (Chew, Derek P.)
    贡献者: 運健系
    关键词: High-sensitivity troponin
    chronic kidney disease
    coronary artery disease
    myocardial injury
    dialysis
    日期: 2020-06-30
    上传时间: 2020-11-03 10:57:58 (UTC+8)
    摘要: Acute myocardial infarction (MI) represents one of the most common hospital encounters, with significant short-term and long-term morbidity and mortality, and frequently occurs in patients with chronic kidney disease (CKD). Cardiac troponin is an exquisitely sensitive biomarker for myocardial injury and plays an essential role in the diagnosis, risk-stratification, and management of MI. In 2017, the United States Food and Drug Administration approved Roche Diagnostics' 5th generation high-sensitivity cardiac troponin (hs-cTn) for clinical use. Whilst the improved analytical sensitivity of these new high-sensitivity troponin assays facilitate early diagnosis of MI, it also frequently identifies troponin elevations above the conventional reference threshold in the context of non-coronary conditions such as renal dysfunction, and can represent a major diagnostic challenge to clinicians. Furthermore, the optimal management strategy of patients with troponin elevation and high comorbidity burden, a common issue in patients with CKD, remains undefined. In recent years, there has been substantial research and progress undertaken in this rapidly evolving area. In this review, we aim to provide clinicians with an overview of hs-cTn in the setting of CKD as well as an update on its application and the particular considerations involved in the management of myocardial infarction, stable coronary artery disease and myocardial injury in this high risk population.
    關聯: REVIEWS IN CARDIOVASCULAR MEDICINE 卷冊: 21 期: 2 頁數: 191-203
    显示于类别:[運動與健康促進學系] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML262检视/开启


    检视Licence

    在CCUR中所有的数据项都受到原著作权保护.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈